Koel Dutta

506 total citations
10 papers, 216 citations indexed

About

Koel Dutta is a scholar working on Infectious Diseases, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Koel Dutta has authored 10 papers receiving a total of 216 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Genetics. Recurrent topics in Koel Dutta's work include COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Koel Dutta is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Koel Dutta collaborates with scholars based in India and United States. Koel Dutta's co-authors include Amerta Ghosh, Anoop Misra, Samit Ghosal, Binayak Sinha, Ritesh Gupta, Abha Mishra, Irshad Ahmad Ansari, Harsh Mahajan, Shivam Pandey and Surya Prakash Bhatt and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and Diabetes & Metabolic Syndrome Clinical Research & Reviews.

In The Last Decade

Koel Dutta

8 papers receiving 206 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koel Dutta India 6 123 44 41 36 28 10 216
Maria Overvad Denmark 6 151 1.2× 23 0.5× 54 1.3× 35 1.0× 11 0.4× 11 242
Uzma Ishaq Pakistan 9 113 0.9× 26 0.6× 25 0.6× 53 1.5× 27 1.0× 24 256
Martha Carnalla Mexico 7 63 0.5× 18 0.4× 15 0.4× 30 0.8× 18 0.6× 29 188
Mercy Joseph Saudi Arabia 4 165 1.3× 10 0.2× 40 1.0× 24 0.7× 13 0.5× 10 202
Francesca Grosso Italy 8 85 0.7× 6 0.1× 74 1.8× 42 1.2× 22 0.8× 17 194
Abdullah Alkandari Kuwait 9 83 0.7× 105 2.4× 5 0.1× 13 0.4× 9 0.3× 19 325
Sarah Reda Germany 6 208 1.7× 5 0.1× 62 1.5× 112 3.1× 38 1.4× 10 321
Wafa Khan India 7 160 1.3× 6 0.1× 54 1.3× 76 2.1× 33 1.2× 13 340
Rama Vunnam United States 6 190 1.5× 6 0.1× 16 0.4× 22 0.6× 42 1.5× 13 322
Yuanhao Zu United States 7 102 0.8× 11 0.3× 7 0.2× 6 0.2× 39 1.4× 18 204

Countries citing papers authored by Koel Dutta

Since Specialization
Citations

This map shows the geographic impact of Koel Dutta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koel Dutta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koel Dutta more than expected).

Fields of papers citing papers by Koel Dutta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koel Dutta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koel Dutta. The network helps show where Koel Dutta may publish in the future.

Co-authorship network of co-authors of Koel Dutta

This figure shows the co-authorship network connecting the top 25 collaborators of Koel Dutta. A scholar is included among the top collaborators of Koel Dutta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koel Dutta. Koel Dutta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Dutta, Koel, Amrita Ghosh, Ritesh Gupta, et al.. (2025). Independent effects of Metformin and Dapagliflozin on Fetuin-A, hepatic and pancreatic fat, and hepatic fibrosis in Asian Indians with type 2 diabetes. Scientific Reports. 15(1). 42156–42156.
2.
Dutta, Koel, et al.. (2025). Heartbreak From Gilteritinib: Two Case Reports of Delayed Onset Cardiotoxicity. Case Reports in Cardiology. 2025(1). 1976122–1976122.
3.
Dutta, Koel, et al.. (2024). Acanthosis nigricans independently predicts hepatic fibrosis in people with type 2 diabetes in North India. Primary care diabetes. 18(2). 224–229. 3 indexed citations
4.
Ansari, Irshad Ahmad, et al.. (2023). Sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes mellitus and moderate to severe hepatic fibrosis: A retrospective study. Clinical Nutrition ESPEN. 57. 305–310. 5 indexed citations
5.
Ghosh, Amerta, Koel Dutta, Surya Prakash Bhatt, et al.. (2022). Dapagliflozin Improves Body Fat Patterning, and Hepatic and Pancreatic Fat in Patients With Type 2 Diabetes in North India. The Journal of Clinical Endocrinology & Metabolism. 107(6). e2267–e2275. 22 indexed citations
6.
Ghosh, Amerta, et al.. (2021). Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 15(3). 1007–1008. 80 indexed citations
7.
Mishra, Abha, et al.. (2021). Exacerbation of hyperglycemia in patients with type 2 diabetes after vaccination for COVID19: Report of three cases. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 15(4). 102151–102151. 27 indexed citations
8.
Ghosal, Samit, et al.. (2020). Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 14(5). 949–952. 62 indexed citations
9.
Misra, Anoop, et al.. (2020). Dipeptidyl peptidase 4 inhibitors linked bullous pemphigoid in patients with type 2 diabetes mellitus: A series of 13 cases. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 14(3). 213–216. 5 indexed citations
10.
Ghosh, Amerta, et al.. (2020). Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 14(4). 577–578. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Overvad Breakdown of academic impact, for papers by Uzma Ishaq Breakdown of academic impact, for papers by Martha Carnalla Breakdown of academic impact, for papers by Mercy Joseph Breakdown of academic impact, for papers by Francesca Grosso Breakdown of academic impact, for papers by Abdullah Alkandari Breakdown of academic impact, for papers by Sarah Reda Breakdown of academic impact, for papers by Wafa Khan Breakdown of academic impact, for papers by Rama Vunnam Breakdown of academic impact, for papers by Yuanhao Zu
Rankless by CCL
2026